Art

J-GLOBAL ID：200902132572655054   Reference number：01A0200394

抗痴呆薬ドネペジルの経済評価

Author (3)： IKEDA SHUN'YA (慶応大 医) ,  YAMADA YUKARI (慶応大 医) ,  IKEGAMI NAOKI (慶応大 医)
Material： 医療と社会  (Journal of Health Care and Society)
Volume： 10  Issue： 3  Page： 27-38  Publication year： Dec. 15, 2000 
JST Material Number： L3876A  ISSN： 0916-9202  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *health expenditure ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=01A0200394&from=J-GLOBAL&jstjournalNo=L3876A") }}

JST classification (1)： Medical systems  (GB04020H)

Substance index (1)： Donepezil

Reference (31)：

• Anis, A. H., and Y. Gagnon (2000) “Using Economic Evaluations to Make Formulary Coverage Decisions: So Much for Guidelines, ”Ph armacoeconomics. 18: 55-62.
• Beck, J. R., and S. G. Pauker (1983) “The Markov Process in Medical Prognosis, ”Medical D ecision Making. 3: 419-458.
• Gold, M. R., J. E. Siegel, L. B. Russell, and M. C. Weinstein, eds (1996) Cost-Effectiveness in Healt h and Medicine. New York: Oxford Univ ersity Press. (池上直己, 池田俊也, 土麗有紀監訳(1999)『医療の経済評価』医学書院)
• ISOQOL (2000) “7th Annual Uonteronce of the International Society for Quality of Life Research ”(October 29-31, 2000, Vancouver, Canada)
• Homma, A., M. Takeda; Y. Imai, F. Udaka, K. Hasegawa, M. Kameyama, T. Nishimura an d E2000 Study Group (2000) “Clinical Efficacy and Safery of Donepezil on Cognitive and Glo bal Function in Patients with Alzheimer's Di sease”Dementia and Geriatric Cognitive Disorde rs. 11: 299-313.

Terms in the title (4)： 抗痴呆薬 ,  ドネペジル ,  経済 ,  評価